Back to Search
Start Over
The l-arginine/nitric oxide pathway contributes to the acute release of tissue plasminogen activator in vivo in man
- Source :
- Cardiovascular Research. 38:485-492
- Publication Year :
- 1998
- Publisher :
- Oxford University Press (OUP), 1998.
-
Abstract
- Objective : Effective endogenous fibrinolysis requires rapid release of endothelial tissue plasminogen activator (t-PA). Using the nitric oxide synthase inhibitor, l- N G-monomethylarginine (l-NMMA), we examined the contribution of endogenous nitric oxide to substance P-induced t-PA release in vivo in man. Methods : Blood flow and plasma fibrinolytic and haemostatic factors were measured in both forearms of 8 healthy male volunteers who received unilateral brachial artery infusions of substance P (2–8 pmol/min) and l-NMMA (1–4 μg/min). Results : Substance P caused dose-dependent increases in blood flow ( P
- Subjects :
- Adult
Male
medicine.medical_specialty
Endothelium
Physiology
medicine.medical_treatment
Substance P
Nitric oxide
chemistry.chemical_compound
Physiology (medical)
Internal medicine
Plasminogen Activator Inhibitor 1
Fibrinolysis
medicine
Humans
Analysis of Variance
omega-N-Methylarginine
Dose-Response Relationship, Drug
T-plasminogen activator
Plethysmography
Forearm
Endocrinology
medicine.anatomical_structure
chemistry
Regional Blood Flow
Area Under Curve
Tissue Plasminogen Activator
Plasminogen activator inhibitor-1
Omega-N-Methylarginine
Nitric Oxide Synthase
Cardiology and Cardiovascular Medicine
Plasminogen activator
Subjects
Details
- ISSN :
- 17553245 and 00086363
- Volume :
- 38
- Database :
- OpenAIRE
- Journal :
- Cardiovascular Research
- Accession number :
- edsair.doi.dedup.....f41b658d54f51936154bf3d2c15e5a12